Avg closing price
Price range

11 Cathie Wood Recursion Pharmaceuticals Trades

Cathie Wood acquired 20.7 Million Recursion Pharmaceuticals shares worth $305 Million. That's 1.88% of their equity portfolio (18th largest holding). The investor owns 10.95% of the outstanding Recursion Pharmaceuticals stock. The first Recursion Pharmaceuticals trade was made in Q2 2021. Since then Cathie Wood bought shares seven more times and sold shares on three occasions. The stake costed the investor $213 Million, netting the investor a gain of 43% so far.

Avg closing price
Price range
Increased shares by 200.4% (+13.8 Million shares) Q4 2023
Avg closing price $7.13
Price range $5.09 - $10.79
Increased shares by 45.1% (+2.14 Million shares) Q3 2023
Avg closing price $9.98
Price range $6.59 - $15.86
Increased shares by 32.5% (+1.16 Million shares) Q2 2023
Avg closing price $7.00
Price range $4.56 - $9.94
Increased shares by 15.4% (+477 Thousand shares) Q1 2023
Avg closing price $7.93
Price range $6.42 - $9.64
Sold 7.7% shares (-260 Thousand shares) Q4 2022
Avg closing price $9.81
Price range $7.16 - $12.70
Increased shares by 23.0% (+628 Thousand shares) Q3 2022
Avg closing price $10.13
Price range $7.83 - $13.60
Sold 3.4% shares (-95.1 Thousand shares) Q2 2022
Avg closing price $6.69
Price range $5.04 - $9.26
Increased shares by 26.7% (+595 Thousand shares) Q1 2022
Avg closing price $10.63
Price range $6.16 - $18.03
Sold 13.9% shares (-362 Thousand shares) Q4 2021
Avg closing price $18.82
Price range $16.14 - $21.86
Increased shares by 9.0% (+215 Thousand shares) Q3 2021
Avg closing price $28.34
Price range $19.03 - $41.33
New holding (+2.38 Million shares) Q2 2021
Avg closing price $29.60
Price range $21.06 - $37.42

News about Recursion Pharmaceuticals Inc - Class A and Cathie Wood

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!